Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1990 3
1991 5
1992 5
1993 6
1994 7
1995 7
1996 8
1997 5
1998 9
1999 11
2000 7
2001 8
2002 4
2003 8
2004 7
2005 7
2006 5
2007 9
2008 8
2009 13
2010 8
2011 5
2012 6
2013 12
2014 6
2015 9
2016 4
2017 9
2018 11
2019 2
2020 6
2021 3
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

209 results
Results by year
Filters applied: . Clear all
Page 1
Tryptophan depletion results in tryptophan-to-phenylalanine substitutants.
Pataskar A, Champagne J, Nagel R, Kenski J, Laos M, Michaux J, Pak HS, Bleijerveld OB, Mordente K, Navarro JM, Blommaert N, Nielsen MM, Lovecchio D, Stone E, Georgiou G, de Gooijer MC, van Tellingen O, Altelaar M, Joosten RP, Perrakis A, Olweus J, Bassani-Sternberg M, Peeper DS, Agami R. Pataskar A, et al. Among authors: van tellingen o. Nature. 2022 Mar;603(7902):721-727. doi: 10.1038/s41586-022-04499-2. Epub 2022 Mar 9. Nature. 2022. PMID: 35264796 Free PMC article.
Tumour-specific proline vulnerability uncovered by differential ribosome codon reading.
Loayza-Puch F, Rooijers K, Buil LC, Zijlstra J, Oude Vrielink JF, Lopes R, Ugalde AP, van Breugel P, Hofland I, Wesseling J, van Tellingen O, Bex A, Agami R. Loayza-Puch F, et al. Among authors: van tellingen o. Nature. 2016 Feb 25;530(7591):490-4. doi: 10.1038/nature16982. Epub 2016 Feb 15. Nature. 2016. PMID: 26878238
An Experimenter's Guide to Glioblastoma Invasion Pathways.
de Gooijer MC, Guillén Navarro M, Bernards R, Wurdinger T, van Tellingen O. de Gooijer MC, et al. Among authors: van tellingen o. Trends Mol Med. 2018 Sep;24(9):763-780. doi: 10.1016/j.molmed.2018.07.003. Epub 2018 Jul 30. Trends Mol Med. 2018. PMID: 30072121 Review.
Uncoupling DNA damage from chromatin damage to detoxify doxorubicin.
Qiao X, van der Zanden SY, Wander DPA, Borràs DM, Song JY, Li X, van Duikeren S, van Gils N, Rutten A, van Herwaarden T, van Tellingen O, Giacomelli E, Bellin M, Orlova V, Tertoolen LGJ, Gerhardt S, Akkermans JJ, Bakker JM, Zuur CL, Pang B, Smits AM, Mummery CL, Smit L, Arens R, Li J, Overkleeft HS, Neefjes J. Qiao X, et al. Among authors: van tellingen o. Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15182-15192. doi: 10.1073/pnas.1922072117. Epub 2020 Jun 17. Proc Natl Acad Sci U S A. 2020. PMID: 32554494 Free PMC article.
The G2 checkpoint-a node-based molecular switch.
de Gooijer MC, van den Top A, Bockaj I, Beijnen JH, Würdinger T, van Tellingen O. de Gooijer MC, et al. Among authors: van tellingen o. FEBS Open Bio. 2017 Mar 4;7(4):439-455. doi: 10.1002/2211-5463.12206. eCollection 2017 Apr. FEBS Open Bio. 2017. PMID: 28396830 Free PMC article.
Buparlisib is a brain penetrable pan-PI3K inhibitor.
de Gooijer MC, Zhang P, Buil LCM, Çitirikkaya CH, Thota N, Beijnen JH, van Tellingen O. de Gooijer MC, et al. Among authors: van tellingen o. Sci Rep. 2018 Jul 17;8(1):10784. doi: 10.1038/s41598-018-29062-w. Sci Rep. 2018. PMID: 30018387 Free PMC article.
Strategies to target drugs to gliomas and CNS metastases of solid tumors.
Milojkovic Kerklaan B, van Tellingen O, Huitema AD, Beijnen JH, Boogerd W, Schellens JH, Brandsma D. Milojkovic Kerklaan B, et al. Among authors: van tellingen o. J Neurol. 2016 Mar;263(3):428-40. doi: 10.1007/s00415-015-7919-9. Epub 2015 Oct 17. J Neurol. 2016. PMID: 26477024 Review.
SLC1A3 contributes to L-asparaginase resistance in solid tumors.
Sun J, Nagel R, Zaal EA, Ugalde AP, Han R, Proost N, Song JY, Pataskar A, Burylo A, Fu H, Poelarends GJ, van de Ven M, van Tellingen O, Berkers CR, Agami R. Sun J, et al. Among authors: van tellingen o. EMBO J. 2019 Oct 4;38(21):e102147. doi: 10.15252/embj.2019102147. Epub 2019 Sep 16. EMBO J. 2019. PMID: 31523835 Free PMC article.
209 results